Previous studies reported that lncRNA SPRY4‐IT1 upregulates EZH2 to exert oncogenic properties in cholangiocarcinoma and bladder cancer by sponging miR‐101‐3p.10, 20. This evidence concerns the gene EZH2 and cholangiocarcinoma.